COYA

Coya Therapeutics, Inc.

COYA · CIK 0001835022 · Annual (10-K) · Last 3 years

Financial Trends

Revenue$4M
20222024
Net Income−$15M
20222024
Operating CF−$10M
20222024
Free Cash Flow
20222024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕
Revenue$0.0B$0.0B—
Cost of Revenue———
Gross Profit———
R&D Expense———
SG&A Expense———
Operating Income$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B
EPS (Basic)$-0.98$-0.79$-4.73
EPS (Diluted)$-0.98$-0.79$-4.73

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕
Total Assets$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$-0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B$-0.0B
Capital Expenditures———
Financing Cash Flow$0.0B$0.0B$0.0B
← Companies